Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
Revenue
Regeneron Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Moderna Inc
NASDAQ:MRNA
|
Revenue
$6.8B
|
CAGR 3-Years
104%
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
Regeneron Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Regeneron Pharmaceuticals Inc
Breakdown by Segments
Regeneron Pharmaceuticals Inc
Total Revenue:
13.1B
USD
|
Net Product Sales:
7.1B
USD
|
Collaboration Revenue:
5.5B
USD
|
Regeneron's Share Of Profits In Connection Wi...:
1.4B
USD
|
Libtayo:
863.1m
USD
|
Other Revenue:
536.1m
USD
|
Reimbursement For Manufacturing Of Commercial...:
111.1m
USD
|
"Next Generation" Covid Antibodies:
50.4m
USD
|
Sales-Based Milestones Earned:
50m
USD
|
See Also
What is Regeneron Pharmaceuticals Inc's Revenue?
Revenue
13.1B
USD
Based on the financial report for Dec 31, 2023, Regeneron Pharmaceuticals Inc's Revenue amounts to 13.1B USD.
What is Regeneron Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
20%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Regeneron Pharmaceuticals Inc have been 16% over the past three years , 14% over the past five years , and 20% over the past ten years .